Application of nutrigenomic concepts to Type 2 diabetes mellitus

被引:32
|
作者
Kaput, Jim
Noble, Janelle
Hatipoglu, Betul
Kohrs, Kari
Dawson, Kevin
Bartholomew, Amelia
机构
[1] Univ Calif Davis, Ctr Excellence Nutr Genom, Davis, CA 95616 USA
[2] Univ Illinois, Dept Surg, Lab Nutrigenom Med, Chicago, IL 60612 USA
[3] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA
[4] Univ Illinois, Med Ctr, Nutr & Wellness Ctr, Med Ctr Outpatient Care Ctr, Chicago, IL 60612 USA
关键词
nutrigenomics; Type 2 diabetes mellitus;
D O I
10.1016/j.numecd.2006.11.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The genetic makeup that individuals inherit from their ancestors is responsible for variation in responses to food and susceptibility to chronic diseases such as Type 2 diabetes mellitus (T2DM). Common variations in gene sequences, such as single nucleotide polymorphisms, produce differences in complex traits such as height or weight potential, food metabolism, food-gene interactions, and disease susceptibilities. Nutritional genomics, or nutrigenomics, is the study of how foods affect the expression of genetic information in an individual and how an individual's genetic makeup affects the metabolism and response to nutrients and other bioactive components in food. Since both diet and genes alter one's health and susceptibitity to disease, identifying genes that are regulated by diet and that cause or contribute to chronic diseases could result in the development of diagnostic tools, individualized intervention, and eventually strategies for maintaining health. Translating this research through clinical studies promises contributions to the development of personalized medicine that includes nutritional as well as drug interventions. Reviewed here are the key nutrigenomic concepts that help explain aspects of the development and complexity of T2DM. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 103
页数:15
相关论文
共 50 条
  • [21] Type 2 diabetes mellitus
    Skelly, Anne H.
    NURSING CLINICS OF NORTH AMERICA, 2006, 41 (04) : 531 - +
  • [22] Application of the Conversation Map™ in Type 2 Diabetes Mellitus with Insulin Treatment
    Li, Ching Lu
    Yang, Yi Sun
    Wu, Yueh Chu
    Lu, Yin Li
    Kornelius, Edy
    Chen, Yu Ju
    Lin, Yu Tze
    Huang, Chien Ning
    DIABETES, 2014, 63 : A178 - A178
  • [23] The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus
    Munir, Kashif M.
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2331 - 2341
  • [24] Diabetes mellitus Type 1 and Type 2
    Henzen, Christoph
    Fischli, Stefan
    THERAPEUTISCHE UMSCHAU, 2020, 77 (07) : 287 - 287
  • [25] Diabetes mellitus: Type I or type 2?
    Rapaport, R
    Wallach, E
    Greig, F
    Iazzetti, L
    JOURNAL OF PEDIATRICS, 2001, 138 (04): : 612 - 612
  • [26] Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus
    Lutz, Thomas A. A.
    NATURE REVIEWS ENDOCRINOLOGY, 2023, 19 (06) : 350 - 360
  • [27] Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus
    Thomas A. Lutz
    Nature Reviews Endocrinology, 2023, 19 : 350 - 360
  • [28] Diabetes mellitus, medications for type 2 diabetes mellitus, and cancer risk
    La Vecchia, Carlo
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (10): : 1357 - 1358
  • [29] Mild impairments in cognition in patients with type 2 diabetes mellitus: the use of the concepts MCI and CIND
    van den Berg, E
    Kessels, RPC
    de Haan, EHF
    Kappelle, LJ
    Biessels, GJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (10): : 1466 - 1467
  • [30] DIABETES MELLITUS - CURRENT CONCEPTS
    MARTIN, MM
    AMERICAN JOURNAL OF NURSING, 1966, 66 (03) : 510 - 514